← Back to Search

Emotional Awareness and Expression Therapy for Migraine

N/A
Recruiting
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A migraine disability assessment scores higher than 6.
Diagnosis of either episodic or chronic migraine (with or without aura) by a licensed neurologist.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at three months followup after end of treatment
Awards & highlights

Study Summary

This trial aims to test a new therapy to treat migraines. Participants attend 8 online sessions with lectures, exercises, discussion, and assignments. Questionnaires required to measure progress. Participants benefit with no cost.

Who is the study for?
This trial is for adults aged 18-80 with a diagnosis of episodic or chronic migraine, experiencing at least 4 migraine days per month. They must have had migraines for over a year and be on a stable medication regimen for the last 3 months. People with serious psychiatric disorders, recent changes in migraine meds, substance abuse issues, or involved in other studies can't join.Check my eligibility
What is being tested?
The study tests Emotional Awareness and Expression Therapy (EAET) to see if it reduces the frequency and severity of migraines. Participants will attend eight weekly online sessions that include lectures, exercises, discussions, and homework assignments.See study design
What are the potential side effects?
Since EAET is a behavioral intervention involving therapy sessions rather than medication, there may not be typical 'side effects.' However, discussing emotional topics could potentially cause temporary discomfort or emotional distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My migraines significantly impact my daily life.
Select...
I have been diagnosed with migraine by a neurologist.
Select...
My migraines significantly impact my daily life.
Select...
My medication has not changed in the last 3 months.
Select...
I have had migraines for over a year.
Select...
I experience at least 4 migraine days each month.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month before the treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month before the treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the number of migraine days in a month after treatment compared to baseline.
Number of migraine days in a month at baseline.
Secondary outcome measures
Allodynia levels at baseline.
Anxiety levels at baseline.
Change in allodynia after treatment compared to baseline.
+15 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Emotional Awareness and Expression Therapy (EAET)Experimental Treatment1 Intervention
In this experimental arm, participants are required to attend 8 online sessions, and fill out questionnaires before treatment, immediately after treatment, and at a 3-month follow-up.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Emotional Awareness and Expression Therapy
2019
N/A
~240

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,098 Previous Clinical Trials
1,778,610 Total Patients Enrolled
1 Trials studying Migraine
109 Patients Enrolled for Migraine
Wayne State UniversityOTHER
307 Previous Clinical Trials
108,444 Total Patients Enrolled

Media Library

Emotional Awareness and Expression Therapy (EAET) Clinical Trial Eligibility Overview. Trial Name: NCT05755698 — N/A
Migraine Research Study Groups: Emotional Awareness and Expression Therapy (EAET)
Migraine Clinical Trial 2023: Emotional Awareness and Expression Therapy (EAET) Highlights & Side Effects. Trial Name: NCT05755698 — N/A
Emotional Awareness and Expression Therapy (EAET) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755698 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently recruiting participants for this trial?

"The clinicaltrials.gov data confirms that, as of this moment, the study is not recruiting patients. This trial was originally published on March 4th 2023 and underwent its last amendment on February 22nd 2023. However, there are still 168 other studies seeking to enrol participants."

Answered by AI

Could I be included in the sample for this investigation?

"In order to qualify for this clinical trial, prospective participants should suffer from migraine and be of an age between 18 years old and 80. The total number of patients accepted into the study is limited to 20 people."

Answered by AI

Is eligibility for this clinical trial restricted to those aged 70 and below?

"As stipulated by the trial inclusions, individuals aged 18 to 80 are qualified for this study. Furthermore, there are 34 studies available for those under 18 and 112 for seniors above 65 years of age."

Answered by AI

What is the culmination that researchers are hoping to achieve with this clinical investigation?

"This clinical trial's primary endpoint is to ascertain the alteration in migraine days per month before and after treatment. Secondary outcomes include measuring changes in quality of life via a Migraine-Specific Quality of Life questionnaire, assessing long term effects on quality of life at 3 months post-treatment, as well as evaluating levels of Allodynia with an allodynia questionnaire ranging from 0 to 24."

Answered by AI

Who else is applying?

What state do they live in?
Tennessee
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
Recent research and studies
clinicaltrials.govStudy
Emotional Awareness and Expression Therapy (EAET) for Migraine
Dan Kaufmann, Ph.D. 2023. "Emotional Awareness and Expression Therapy (EAET) for Migraine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05755698.
All > Migraine
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top